Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2014 08:30 ET | Source: Lipocine Inc.

Lipocine Announces Financial and Operational Results for the First Quarter of 2014

SALT LAKE CITY, May 13, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (Nasdaq:LPCN), a specialty pharmaceutical company, announced today announced financial results for the quarter ended March 31, 2014, as...
April 29, 2014 08:00 ET | Source: Lipocine Inc.

Lipocine Announces Completion of Enrollment in its SOAR Phase 3 Study for Oral Testosterone Replacement Therapy

- Top-line Efficacy Data Expected in 3Q14 - NDA filing expected in 2H15 SALT LAKE CITY, April 29, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (Nasdaq:LPCN), a specialty pharmaceutical company, today...
March 18, 2014 08:30 ET | Source: Lipocine Inc.

Lipocine to Begin Trading on the NASDAQ Capital Market

SALT LAKE CITY, March 18, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN), a specialty pharmaceutical company, today announced that it has received confirmation that its application to list the...
March 05, 2014 08:30 ET | Source: Lipocine Inc.

Lipocine to Present at the 26th Annual ROTH Conference

SALT LAKE CITY, March 5, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN), a specialty pharmaceutical company, today announced Mahesh Patel, President and CEO, and Morgan Brown, Executive Vice...
February 10, 2014 08:30 ET | Source: Lipocine Inc.

Lipocine Announces First Patient Dosed in Phase 3 Study for Oral Testosterone Replacement Therapy

SALT LAKE CITY, Feb. 10, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN), a specialty pharmaceutical company, today announced that the first patient has been dosed in its Study of Oral Androgen...
February 04, 2014 08:30 ET | Source: Lipocine Inc.

Lipocine to Present at the 2014 Leerink Global Healthcare Conference

SALT LAKE CITY, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN), a specialty pharmaceutical company, today announced Mahesh Patel, President and CEO, and Morgan Brown, Executive Vice...
January 07, 2014 16:00 ET | Source: Lipocine Inc.

Lipocine Announces New Appointments to Its Board of Directors

SALT LAKE CITY, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN) (OTCBB:LPCN), a specialty pharmaceutical company, today announced changes to the Company's Board of Directors, including the...
December 13, 2013 16:30 ET | Source: Lipocine Inc.

Lipocine Chairman Receives Honorary Doctor of Science Degree From the University of Michigan

SALT LAKE CITY, Dec. 13, 2013 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN) (OTCBB:LPCN), a specialty pharmaceutical company, today announced that Dr. William I. Higuchi will receive an honorary...
December 06, 2013 16:00 ET | Source: Lipocine Inc.

Lipocine Inc. Announces Exercise and Closing of Over-Allotment Option

SALT LAKE CITY, Dec. 6, 2013 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN), a specialty pharmaceutical company, today announced that the underwriters of its previously announced public offering have...
November 27, 2013 08:30 ET | Source: Lipocine Inc.

Lipocine Inc. Announces Pricing of Public Offering of Common Stock

SALT LAKE CITY, Nov. 27, 2013 (GLOBE NEWSWIRE) -- Lipocine Inc. (OTCQB:LPCN) (OTCBB:LPCN), a specialty pharmaceutical company, today announced the pricing of an underwritten public offering of...